Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 2
1984 1
1986 2
1987 1
1999 1
2002 1
2004 1
2006 3
2009 1
2013 4
2014 4
2017 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

20 results
Results by year
Filters applied: . Clear all
Page 1
Blushing primary cardiac angiosarcoma.
Khanji M, Lee E, Ionescu A. Khanji M, et al. Heart. 2014 Feb;100(3):266. doi: 10.1136/heartjnl-2013-304745. Epub 2013 Sep 23. Heart. 2014. PMID: 24064225 No abstract available.
Vascular-targeted agents for the treatment of angiosarcoma.
Young RJ, Woll PJ, Staton CA, Reed MW, Brown NJ. Young RJ, et al. Cancer Chemother Pharmacol. 2014 Feb;73(2):259-70. doi: 10.1007/s00280-013-2345-0. Epub 2013 Nov 20. Cancer Chemother Pharmacol. 2014. PMID: 24253175
IFN-alpha1,8 inhibits tumor-induced angiogenesis in murine angiosarcomas.
Taylor KL, Oates RK, Grane R, Leaman DW, Borden EC, Lindner DJ. Taylor KL, et al. J Interferon Cytokine Res. 2006 May;26(5):353-61. doi: 10.1089/jir.2006.26.353. J Interferon Cytokine Res. 2006. PMID: 16689662
Overexpression of gankyrin in mouse hepatocytes induces hemangioma by suppressing factor inhibiting hypoxia-inducible factor-1 (FIH-1) and activating hypoxia-inducible factor-1.
Liu Y, Higashitsuji H, Higashitsuji H, Itoh K, Sakurai T, Koike K, Hirota K, Fukumoto M, Fujita J. Liu Y, et al. Biochem Biophys Res Commun. 2013 Mar 1;432(1):22-7. doi: 10.1016/j.bbrc.2013.01.093. Epub 2013 Feb 1. Biochem Biophys Res Commun. 2013. PMID: 23376718
20 results
Jump to page
Feedback